These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


97 related items for PubMed ID: 21303380

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Genomics and signaling pathways in hepatocellular carcinoma.
    Villanueva A, Newell P, Chiang DY, Friedman SL, Llovet JM.
    Semin Liver Dis; 2007 Feb; 27(1):55-76. PubMed ID: 17295177
    [Abstract] [Full Text] [Related]

  • 3. Molecular targeted therapy for hepatocellular carcinoma: bench to bedside.
    Kudo M.
    Dig Dis; 2011 Feb; 29(3):273-7. PubMed ID: 21829017
    [Abstract] [Full Text] [Related]

  • 4. Molecular pathogenesis of hepatocellular carcinoma: altering transforming growth factor-β signaling in hepatocarcinogenesis.
    Yamazaki K, Masugi Y, Sakamoto M.
    Dig Dis; 2011 Feb; 29(3):284-8. PubMed ID: 21829019
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pathogenesis of hepatocellular carcinoma and molecular therapies.
    Mínguez B, Tovar V, Chiang D, Villanueva A, Llovet JM.
    Curr Opin Gastroenterol; 2009 May; 25(3):186-94. PubMed ID: 19387255
    [Abstract] [Full Text] [Related]

  • 7. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE, Wink J, Alers JC, IJzermans JN, Schalm SW, de Man RA, van Dekken H.
    J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
    [Abstract] [Full Text] [Related]

  • 8. Molecular pathogenesis of hepatocellular carcinoma.
    McKillop IH, Moran DM, Jin X, Koniaris LG.
    J Surg Res; 2006 Nov; 136(1):125-35. PubMed ID: 17023002
    [Abstract] [Full Text] [Related]

  • 9. Proliferative drive and liver carcinogenesis: too much of a good thing?
    Teoh NC.
    J Gastroenterol Hepatol; 2009 Dec; 24(12):1817-25. PubMed ID: 20002941
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Genetics of hepatobiliary carcinogenesis.
    Nault JC, Zucman-Rossi J.
    Semin Liver Dis; 2011 May; 31(2):173-87. PubMed ID: 21538283
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
    Xue KX.
    Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies.
    Marquardt JU, Galle PR, Teufel A.
    J Hepatol; 2012 Jan; 56(1):267-75. PubMed ID: 21782758
    [Abstract] [Full Text] [Related]

  • 17. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Xue WJ, Li C, Zhou XJ, Guan HG, Qin L, Li P, Wang ZW, Qian HX.
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
    [Abstract] [Full Text] [Related]

  • 18. [Hepatitis viruses and hepatocarcinogenesis].
    Kiss A, Lotz G, Kaposi NP, Schaff Z.
    Orv Hetil; 2002 Jan 13; 143(2):83-6. PubMed ID: 11868453
    [Abstract] [Full Text] [Related]

  • 19. [Hepatocellular carcinoma: molecular biology aspects].
    Blum HE.
    Zentralbl Chir; 1994 Jan 13; 119(11):759-63. PubMed ID: 7846955
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.